| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 07/17/2002 | EP0939629A4 Thiol sulfonamide metalloprotease inhibitors |
| 07/17/2002 | EP0888340B1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 07/17/2002 | CN1087735C Process for preparation of pesticidal 1-(haloaryl) heteroyclic compounds |
| 07/16/2002 | US6420559 1-(4-arylpiperazin-1-yl)-ω-[N-(α,ω-dicarboximido)]-alkanes useful as uro-selective α1-adrenoceptor blockers |
| 07/16/2002 | US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury |
| 07/16/2002 | US6420424 CCR-3 receptor antagonists |
| 07/16/2002 | US6420416 Administering nefiracetam |
| 07/16/2002 | US6420415 Thiol compounds, their production and use |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |
| 07/16/2002 | US6420396 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 07/16/2002 | US6420392 Paf receptor antagonists and/or by inhibiting the enzyme 5-lipoxygenase. |
| 07/16/2002 | US6420390 Heteroarylpiperidines and their use as antipsychotics |
| 07/16/2002 | US6420366 1-(4-arylpiperazin-1-yl)-ω-[N-(αω-dicarboximido)]-alkanes useful as uro-selective α1-adrenoceptor blockers |
| 07/16/2002 | US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis, |
| 07/16/2002 | US6420316 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/11/2002 | WO2002053525A1 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof |
| 07/11/2002 | WO2002053153A1 Medicines for treatment and prevention of neurogenic pain |
| 07/11/2002 | WO2002026750A3 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation |
| 07/11/2002 | WO2002026705A3 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation |
| 07/11/2002 | WO2002024632A3 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
| 07/11/2002 | WO2001017568A3 Bioconjugation in vivo to pulmonary or blood components |
| 07/11/2002 | US20020091286 Method for producing ortho-alkylated benzoic acid derivatives |
| 07/11/2002 | US20020091280 Chiral ferrocene phosphines and their use in asymmetric catalytic reactions |
| 07/11/2002 | US20020091266 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/11/2002 | US20020091210 Group 8-10 transition metal based supported catalyst where the support is treated with a pore-filling agent; improved the catalyst productivity in the presence of hydrogen |
| 07/11/2002 | US20020091153 Novel anandamide amidase inhibitors as analgesic agents |
| 07/11/2002 | US20020091142 Therapeutic or prophylactic treatment of transplant rejection and inflammatory and autoimmune diseases. |
| 07/11/2002 | US20020091120 2-substituted heterocyclic compounds for treating multidrug resistance |
| 07/11/2002 | US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 07/11/2002 | US20020091068 Succinimide-acid compounds and derivatives thereof |
| 07/11/2002 | CA2433580A1 Tertiary perfluorocycloamines as a basis for gas transport emulsions and process for preparing thereof |
| 07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
| 07/10/2002 | EP1220836A2 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 07/10/2002 | EP1220831A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 07/10/2002 | CN1358173A Heterocyclic dicarboxylic acid diamide derivatives, agricul-horticul tural insecticides and method of using the same |
| 07/10/2002 | CN1087294C Novel compounds |
| 07/10/2002 | CN1087289C Novel process for the production of amorphous [R-(R,R.)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt |
| 07/10/2002 | CN1087288C Crystalline [R-(R+,R+)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(5-methylethyl)-3-phenyl-4-(phenylamino) carbonyl]-1H-pyrole-1-heptanoic acid hemi-calcium salt (atorvastatin) |
| 07/10/2002 | CN1087285C Basic group substituted benzoyl guaniazine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same |
| 07/10/2002 | CN1087283C New LH-RH antigonists with improved effectiveness |
| 07/09/2002 | US6417387 α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 07/09/2002 | US6417372 Specified ratio of two polymorphs, given particle sizes; storage stability; pesticidal suspensions such as of chlorfenapyr; prepared by aging and milling particles |
| 07/09/2002 | US6417370 Arylphenyl-substituted cyclic keto-enols |
| 07/09/2002 | US6417361 Fluorination agent and preparation and use of same |
| 07/09/2002 | US6417220 A medicine for preventive/treatment of disease caused by mitochondrial membrane depolarization because of elevation of intracellular calcium ion concentration; benzodiazepine receptor antagonist, e.g.,nefiracetam; antiischemic agents |
| 07/09/2002 | US6417219 Enzyme inhibitors and osteoarthritis |
| 07/09/2002 | US6417209 Heterocyclic ketone and thioester compounds and uses |
| 07/09/2002 | US6417161 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors |
| 07/04/2002 | WO2002051983A2 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | WO2002051836A1 Dipeptidyl peptidase iv inhibitor |
| 07/04/2002 | WO2002051804A1 Crystalline forms of atorvastatin |
| 07/04/2002 | US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates |
| 07/04/2002 | US20020086887 N-Acylsulfonamide apoptosis promoters |
| 07/04/2002 | US20020086815 Cancer therapy; for skin cancer, myeloids |
| 07/04/2002 | US20020083804 Removal tool for locking nut, bolt and clip systems and assemblies |
| 07/04/2002 | DE10063294A1 New N-(heterocyclyl-alkyl)-fused norbornylamine derivatives, are NHE3 inhibitors useful e.g. for treating respiratory disorders, renal failure, intestinal dysfunction, lipid metabolism disorders or proliferative diseases |
| 07/04/2002 | CA2626317A1 Crystalline forms of atorvastatin |
| 07/04/2002 | CA2623600A1 Crystalline forms of atorvastatin |
| 07/04/2002 | CA2623599A1 Crystalline forms of atorvastatin |
| 07/04/2002 | CA2622727A1 Crystalline forms of atorvastatin |
| 07/04/2002 | CA2622697A1 Crystalline forms of atorvastatin |
| 07/04/2002 | CA2622477A1 Crystalline forms of atorvastatin |
| 07/04/2002 | CA2433520A1 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | CA2433090A1 Dipeptidyl peptidase iv inhibitor |
| 07/03/2002 | EP1220024A2 Silver halide photographic element |
| 07/03/2002 | EP1219623A1 New esters derived from substituted phenyl-cyclohexyl compounds |
| 07/03/2002 | EP1219611A1 Novel processes for preparing oxazepine derivatives |
| 07/03/2002 | EP1219594A1 New esters derived from substituted phenyl-cyclohexyl compounds |
| 07/03/2002 | EP1218372A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 07/03/2002 | EP1218338A1 Preparation of amino-protected lysine derivatives |
| 07/03/2002 | EP1218336A2 Melanin concentrating hormone antagonist |
| 07/03/2002 | EP0812185B1 Use of angiogenesis suppressors for inhibiting hair growth |
| 07/03/2002 | EP0563345B1 Novel 4-arylpiperazines and 4-arylpiperidines |
| 07/03/2002 | CN1356989A Substituted herbicidal phenyluracils |
| 07/03/2002 | CN1356981A Pharmaceutical compounds |
| 07/03/2002 | CN1356976A Therapeutically and/or nutritionaly enhanced derivatives of active ingredients and orally administrable compsns. contg. same |
| 07/03/2002 | CN1356038A Fungiciding mixture |
| 07/02/2002 | US6414163 Process and intermediate compounds for the preparation of pyrrolidines |
| 07/02/2002 | US6414148 Produce antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals |
| 07/02/2002 | US6414011 Central nervous system disorders |
| 07/02/2002 | US6414005 Brain disorders; alzheimer's disease; parkinson's disease |
| 06/27/2002 | WO2002050069A2 Sulfonylpyrroles for controlling microorganisms |
| 06/27/2002 | WO2002050056A1 Benzylamine derivatives and their use as thrombin inhibitors |
| 06/27/2002 | WO2002050026A1 Process for synthesizing lactam |
| 06/27/2002 | WO2002049993A2 High affinity small molecule c5a receptor modulators |
| 06/27/2002 | WO2002049632A1 Inhibitors against the production and release of inflammatory cytokines |
| 06/27/2002 | WO2002024613A3 Resorcinol derivatives |
| 06/27/2002 | WO2002022592A3 Substituted urea neuropeptide y y5 receptor antagonists |
| 06/27/2002 | WO2001096298A3 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
| 06/27/2002 | WO2001092215A3 Superoxide-generating diazeniumdiolates, compositions comprising same, and methods for using same |
| 06/27/2002 | WO2001053257A3 Compounds having hypolipedemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them |
| 06/27/2002 | US20020082426 Protease inhibitors |
| 06/27/2002 | US20020082265 For treating or preventing emphysema, cancer and dermatological disorders |
| 06/27/2002 | CA2431588A1 Benzylamine derivatives and their use as thrombin inhibitors |
| 06/26/2002 | EP1216994A2 Tricyclic antidepressant derivatives and immunoassay |
| 06/26/2002 | EP1216285A1 Fluorescent maleimides and uses thereof |
| 06/26/2002 | EP1216248A2 Triazolopyrimidine derivatives |
| 06/26/2002 | EP1216229A1 Metallo-organo catalyst for polymerizing unsaturated compounds |
| 06/26/2002 | EP0906096B1 Use of hydroxyprolines for the manufacture of a medicament for inhibiting leukocyte invasion of tissues |
| 06/26/2002 | CN1355811A Integrain receptor antagaonists |